Present day therapy of juvenile idiopathic arthritis with the use of genetically engineered medicines in a third level regional hospital - results and problems

Background. Juvenile idiopathic arthritis is accompanied by severe functional disabilities refractory to standard treatment with methotrexate. Recently introduced genetic engineering has significantly improved the functional state of the patients with persistent disease and stopped the progressive d...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: A. E. Matyunova, L. V. Bregel
Formato: article
Lenguaje:RU
Publicado: Scientific Сentre for Family Health and Human Reproduction Problems 2017
Materias:
Q
Acceso en línea:https://doaj.org/article/b58c11e40cd94dd5a015953c76545188
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!